The purpose of IMSVISUAL is to improve care, research, and education in multiple sclerosis (MS) and other neuroinflammatory disorders by advancing our understanding of the visual system in MS.

The overarching goal of IMSVISUAL is to establish the visual system as a model within which to monitor neurodegeneration, disease progression, demyelination and remyelination, neuroregeneration and neuroplasticity in MS, both for tracking patients, as well as outcome measures in clinical trials.

The consortium emphasizes ocular imaging in MS, relating the visual system to the global MS disease process and is committed to testing therapeutics including putative neuroprotective and remyelinating agents in MS using the visual system as an outcome measure.